THPO and acute myeloid leukemia: They showed that when in co-culture with osteoblasts differentiated from bone-marrow-derived MSCs from acute myeloid leukaemia (AML) patients, cancer cells secreted more thrombopoietin and were more resistant to the chemotherapeutic daunorubicin than when co-cultured with osteoblasts derived from normal control MSCs.